Diamonds and Dogs


Micron (MU) higher following earnings. The DRAM maker is up 2% following better than expected earnings as sales rose 12%. The company is also raising guidance thanks to strong demand for 5G, AI and more cloud base business. Micron was upgraded with a $90 price target.

A tough day for Sarepta Therapeutics (SRPT). A gene therapy biotech is down on news their controlled trial for gene therapy failed to improve the average muscle strength in children with muscular dystrophy.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.